<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39316326</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2193-8229</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Infectious diseases and therapy</Title><ISOAbbreviation>Infect Dis Ther</ISOAbbreviation></Journal><ArticleTitle>Acute Cerebellitis Following COVID-19: Alarming Clinical Presentation Challenged by Normal Paraclinical Findings.</ArticleTitle><Pagination><StartPage>2449</StartPage><EndPage>2453</EndPage><MedlinePgn>2449-2453</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40121-024-01048-4</ELocationID><Abstract><AbstractText>We report the case of an acute cerebellitis following COVID-19 in 32-year-old man who presented with a life-threatening critical cerebellar syndrome contrasting with normal paraclinical findings. Despite this fulminant critical presentation, the patient fully recovered in 37 days after early treatment with high-dose steroids and intravenous immunoglobulins. This case highlights the need for clinicians to be aware of acute cerebellitis following COVID-19, despite normal laboratory, imaging and electroencephalography findings and the importance to start appropriate treatment as soon as possible.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Poloni</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious and Tropical Diseases, Nord Franche-Comté Hospital, 90400, Trévenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamani</LastName><ForeName>Abdoulaye</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious and Tropical Diseases, Nord Franche-Comté Hospital, 90400, Trévenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassis</LastName><ForeName>Valentine</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Infectious and Tropical Diseases, Nord Franche-Comté Hospital, 90400, Trévenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Escoffier</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Infectious and Tropical Diseases, Nord Franche-Comté Hospital, 90400, Trévenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagenkotter</LastName><ForeName>Beate</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nord Franche-Comté Hospital, 90400, Trévenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gendrin</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Infectious and Tropical Diseases, Nord Franche-Comté Hospital, 90400, Trévenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zayet</LastName><ForeName>Souheil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious and Tropical Diseases, Nord Franche-Comté Hospital, 90400, Trévenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klopfenstein</LastName><ForeName>Timothée</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4334-9889</Identifier><AffiliationInfo><Affiliation>Department of Infectious and Tropical Diseases, Nord Franche-Comté Hospital, 90400, Trévenans, France. timothee.klopfenstein@hnfc.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Infect Dis Ther</MedlineTA><NlmUniqueID>101634499</NlmUniqueID><ISSNLinking>2193-6382</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute cerebellitis</Keyword><Keyword MajorTopicYN="N">Ataxia</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cerebellitis</Keyword><Keyword MajorTopicYN="N">Immune-mediated</Keyword></KeywordList><CoiStatement>All named authors confirm that they have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>11</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39316326</ArticleId><ArticleId IdType="pmc">PMC11499496</ArticleId><ArticleId IdType="doi">10.1007/s40121-024-01048-4</ArticleId><ArticleId IdType="pii">10.1007/s40121-024-01048-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chan JL, Murphy KA, Sarna JR. Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review. J Neurol. 2021;268(10):3517–48. 10.1007/s00415-021-10458-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7897737</ArticleId><ArticleId IdType="pubmed">33616739</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021;268(9):3059–71. 10.1007/s00415-021-10406-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7826147</ArticleId><ArticleId IdType="pubmed">33486564</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767–83. 10.1016/S1474-4422(20)30221-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):1–9. 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta EM, Batra A, Clark JR, et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020;7(11):2221–30. 10.1002/acn3.51210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun BT, Badenes R, La-Calle GH, et al. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D) a multicentre cohort study. Lancet Respir Med. 2021;9(3):239–50. 10.1016/S2213-2600(20)30552-X.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832119</ArticleId><ArticleId IdType="pubmed">33428871</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayet S, Klopfenstein T, Kovẚcs R, Stancescu S, Hagenkötter B. Acute cerebral stroke with multiple infarctions and COVID-19, France, 2020. Emerg Infect Dis. 2020;26(9):2258–60. 10.3201/eid2609.201791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454094</ArticleId><ArticleId IdType="pubmed">32453685</ArticleId></ArticleIdList></Reference><Reference><Citation>Plumacker F, Lambert N, Maquet P. Immune-mediated cerebellitis following SARS-CoV-2 infection—a case report and review of the literature. J NeuroVirol. 2023;29(4):507–18. 10.1007/s13365-023-01163-x.</Citation><ArticleIdList><ArticleId IdType="pubmed">37589883</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadakar N, Ghaemmaghami S, Masoompour SM, et al. A first case of acute cerebellitis associated with coronavirus disease (COVID-19): a case report and literature review. Cerebellum. 2020;19(6):911–4. 10.1007/s12311-020-01177-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393247</ArticleId><ArticleId IdType="pubmed">32737799</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner J, Reichen I, Huber M, Abela IA, Weller M, Jelcic I. Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report. BMC Infect Dis. 2021;21(1):298. 10.1186/s12879-021-05987-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7988684</ArticleId><ArticleId IdType="pubmed">33761897</ArticleId></ArticleIdList></Reference><Reference><Citation>Malayala SV, Jaidev P, Vanaparthy R, Jolly TS. Acute COVID-19 cerebellitis: a rare neurological manifestation of COVID-19 infectio. Cureus. 2021;13(10):e18505. 10.7759/cureus.18505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8569692</ArticleId><ArticleId IdType="pubmed">34754665</ArticleId></ArticleIdList></Reference><Reference><Citation>Nepal G, Rehrig JH, Shrestha GS, et al. Neurological manifestations of COVID-19: a systematic review. Crit Care. 2020;24:421. 10.1186/s13054-020-03121-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7356133</ArticleId><ArticleId IdType="pubmed">32660520</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe T, Kakinuma Y, Watanabe K, Kinno R. Acute cerebellitis following COVID-19 infection associated with autoantibodies to glutamate receptors. J Neurovirol. 2023;29(6):731–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10794470</ArticleId><ArticleId IdType="pubmed">37930583</ArticleId></ArticleIdList></Reference><Reference><Citation>Najdaghi S, Narimani Davani D, Hashemian M, Ebrahimi N. Cerebellitis following COVID-19 infection. Heliyon. 2024;10(14):e34497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11305223</ArticleId><ArticleId IdType="pubmed">39113976</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>